Cystic fibrosis affects people of every racial and ethnic group. Of the nearly 40,000 people living with CF in the U.S., approximately 15% are identified as racially or ethnically diverse. Research shows that people of color with CF, particularly people who are Black and Hispanic, experience unique challenges and often have negative experiences that can lead to poorer outcomes. Some of these inequities are referenced in the following data.
Site Search
Showing 1 - 3 of 3 results
4 min read
En la Fundación de la Fibrosis Quística, nos comprometemos con la igualdad, la justicia racial, la diversidad y la inclusión como principios básicos que guían nuestros esfuerzos para brindar a toda persona con fibrosis quística (FQ) la oportunidad de llevar una vida larga y plena.
The Drug Development Pipeline features an extensive list of drugs that are in development or approved for treating cystic fibrosis. For a drug or program to be shown on the pipeline, it must meet certain conditions.
3 min read